Exfoliative dermatitis
☆ In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
Red (burning) Skin Syndrome ― Erythema et scala in toto corpore sunt praecipua indicia Exfoliative dermatitis.
relevance score : -100.0%
ReferencesErythroderma rara est, sed gravis conditio cutis. Cum causa accurata saepe ignota est, potest esse reactionem pharmacologicam vel cancrum subiectum urgeri. Unum commune malignum cum dermatitis exfoliativis coniunctum est lymphoma cutaneus T‑cell, quae signa per menses vel etiam annos post conditionem cutis incipit ostendere, non potuit. Fere hospitalizatio opus est ad primam aestimationem et curationem. Aegroti morbo pharmaco affecti fere bonum diuturnum prospectum habent, quamquam casus sine causa manifesta tendunt ad cursum recurrentem et remittentem. Prognosis causarum cum cancro coniuncto typice pendet a modo in quo cancer progreditur.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Plerumque manifestatur rubor et flaring super 90 % tegumenti corporis. Haec conditio visibilis est signum variarum quaestionum sanitatis, sicut psoriasis, scabies, vel responsio ad quaedam medicamenta.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Frequentissima causa erythrodermatis est exacerbatio morbi cutanei subiecti, qualia sunt psoriasis, dermatitis contactus, dermatitis seborrheica, lichen planus, pityriasis rubra pilaris aut reactiones medicamentorum, ut usus steroidorum topicarum. Primaria manifestatio rarior est et in casibus lymphoma cellulae T cutanei videri solet. Quia interest differentia lymphoma cellulae T cutanei, biopsia conficitur.